NCT02688985), 1-year analysis demonstrated a significant reduction of serum (s) NfL (13.1%, 18.6%, and 30.8%) and CSF NfL levels (24.5%, 40.0%, and 54.7%) in ocrelizumab-treated RMS patients at weeks 12, 24, and 52, suggesting a progressive and sustained reduction in axonal injury with this treatment [44]
Lets break down what the science says about Mounjaro injection sites and how you can make your weekly injection routine as smooth and effective as possible
it is a mental and behavioral one, too
Mean, as we most commonly use it is the average of a group of numbers - you add all the numbers together and then divide by the total number of values in the set
K.Heide-JorgensenU.AndersenI
The takehome is simple: stronger evidence is coming, and it will focus on realworld outcomes rather than just biomarkers